Further RNA-seq results showed that high expression of GPR65 in U2OS cells can induce changes in immune system, metabolism, and signaling processes, and exert tumor inhibition through MAPK and PI3K/AKT signaling pathways. The gene discussed is AKT1; the disease is neoplasm.